Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Predictive Oncology Logo
Predictive Oncology Growth Score
62
CB Rank
125697
Heat Score
43
Predictive Oncology is working with the pharmaceutical, diagnostic, and biotech industries to develop customizable assessment methods.
Founded
obfuscation
PublicPost-IPO Equity Eagan, Minnesota, United States11-50 predictive-oncology.com
Health Care
Health Diagnostics
Medical
Oncology
Pharmaceutical
Overview

Predictive Oncology
Total Funding
obfuscation
Growth Score
62
Heat Score
43

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score62
-8 pts
in past quarter
Heat Score 43
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Predictive Oncology

CB Rank
125697
Predictive Oncology is working with the pharmaceutical, diagnostic, and biotech industries to develop customizable assessment methods.
Founded
obfuscation
PublicPost-IPO Equity Eagan, Minnesota, United States11-50 predictive-oncology.com
Health Care
Health Diagnostics
Medical
Oncology
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Precision Therapeutics Inc.
Also Known As Precision Therapeutics
Operating Status Active
Stock Symbol  NASDAQ:POAI
Company Type For Profit
About the Company

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech.

Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development

of new targeted therapies in collaborations with pharmaceutical companies.

Predictions & Insights

Growth Insight

See this Growth Insight
Predictive Oncology is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

PEDAL Platform
An AI-driven platform integrating a biobank of over 150,000 tumor samples with active machine learning to predict drug response and optimize oncology drug discovery.
3D Tumor Models
Patient-derived 3D organoid and co-culture tumor models for drug testing, mimicking human tissue architecture to better predict clinical outcomes.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 12
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 12
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Predictive Oncology Logo
Post-IPO Equity - Predictive Oncology
—

Investments

Number of Acquisitions 4

Investment Breakdown

Number of Acquisitions 4
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 6 Board Members and Advisors 3 Contacts 9

Employee Profiles

Board Members and Advisors

News

News and Press

News•Dec 2, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 21, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 14, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 7, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

243
-49.38%
 in past month

IT Spend

$57.4KThis year, Predictive Oncology is projected to spend $57.4K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Broadband Logo
Broadband
100
Certificate Programs Logo
Certificate Programs
91
Brother International Logo
Brother International
90

Actively Used Products

18Predictive Oncology uses 18 technology products and services including HTML5, HTML5, and  Starfield SSL, according to G2 Stack.

Active Website Tech Count

3Predictive Oncology is actively using 3 technologies for its website, according to BuiltWith. These include Google Analytics and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is Predictive Oncology's headquarters? Predictive Oncology is located in Eagan, Minnesota, United States.Who invested in Predictive Oncology? Predictive Oncology has 3 investors including Yorkville Advisors and  U.S. Department of Defense.When was the last funding round for Predictive Oncology? Predictive Oncology closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Predictive Oncology's competitors? Alternatives and possible competitors to Predictive Oncology may include SandboxAQ, Insilico Medicine, and  Isomorphic Labs.How much funding has Predictive Oncology raised to date? Predictive Oncology has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|